Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramón Salazar(Institut Català d'Oncologia), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Cornelis J.�H. van de Velde(Leiden University Medical Center), Paul Roepman(Leiden University Medical Center), Gabriel Capellá(Institut Català d'Oncologia), David Kerr(University of Oxford), Vı́ctor Moreno(Ajuntament de L’Hospitalet), Annuska M. Glas(Leiden University Medical Center), Adriana López‐Doriga(Leiden University Medical Center), Peter J.K. Kuppen(Leiden University Medical Center), Cristina Santos(Leiden University Medical Center), Hans Morreau(Leiden University Medical Center), Iris Simón(Leiden University Medical Center), Sjoerd C. Bruin(Leiden University Medical Center), Laura J. van’t Veer(University of California, San Francisco), Christa Dreezen(Leiden University Medical Center), Johan Westerga(Leiden University Medical Center), Corrie A.M. Marijnen(Leiden University Medical Center)
Cited by 540
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
SNPStats: a web tool for the analysis of association studies
|Bioinformatics|2006|2k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k